Clinical Trial

Prebiotic Effects of Mulberry Fruit in Children and Adolescents With Atopic Dermatitis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 25, 2025 (before its estimated February 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This project proposes a randomized controlled human study to explore the prebiotic effects of consuming mulberry juice on atopic dermatitis in children and adolescents. The study aims to investigate the potential of mulberry fruit as a human prebiotic. This human study will recruit up to 120 participants from the Taipei Medical University Hospital (commissioned by the Ministry of Health and Welfare). Participants will be divided into experimental groups and a control group, with a 3-month intervention involving five clinical assessments and three stool collections. The goal is to compare the severity of atopic dermatitis, gut microbiota, and metabolite changes during the 6 days of mulberry juice consumption between the experimental and control groups. This project will help establish mulberry fruit as a potential human prebiotic and adjunctive treatment for alleviating atopic dermatitis in children.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-10-08; most recent amendment 2025-05-20.
Status change: Not Yet Recruiting → Recruiting 2025-03-26
Trial Details
NCT Number NCT06636240
Lead Sponsor Taipei Medical University Shuang Ho Hospital
Conditions Atopic Dermatitis (Eczema), Atopic Dermatitis, Probiotics
Enrollment 120 participants
Start Date 2025-03-17
Primary Completion 2026-02-01 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-25